glp 1 and chronic kidney disease Glucagon-like peptide-1 receptor agonists in diabetic disease: A review of their kidney heart protection GLP-1 RAs, Other Agents, Underused
Description
GLP-1 patches are an emerging technology being studied as an alternative to injectable GLP-1 receptor agonists, which are medications commonly prescribed for type 2 diabetes and weight management
This practice allows the skin to recover and reduces the cumulative irritant effect of the adhesive and medication
Abstract Objectives Glucagon-like peptide 1 (GLP-1) receptor agonists have recently proven to be an effective treatment for type 2 diabetes mellitus (T2DM)
Everyones body and health journey is different, so its important to look at the full picture
[DOI] [PubMed] [Google Scholar] 11.Drucker DJ
The magnitude of these effects was greater than those with open-label liraglutide in the same study [30]
